van der Ende ME - Search Results

1

Current and future applications of dried blood spots in viral disease management.

Snijdewind IJ, van Kampen JJ, Fraaij PL, van der Ende ME, Osterhaus AD, Gruters RA. Snijdewind IJ, et al. Among authors: van der ende me, van kampen jj. Antiviral Res. 2012 Mar;93(3):309-21. doi: 10.1016/j.antiviral.2011.12.011. Epub 2012 Jan 5. Antiviral Res. 2012. PMID: 22244848 Review.

2

Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients.

van der Ende ME, Prins JM, Brinkman K, Keuter M, Veenstra J, Danner SA, Niesters HG, Osterhaus AD, Schutten M. van der Ende ME, et al. AIDS. 2003 Jul;17 Suppl 3:S55-61. doi: 10.1097/00002030-200317003-00008. AIDS. 2003. PMID: 14565610 Clinical Trial.

3

In vitro replication capacity of HIV-2 variants from long-term aviremic individuals.

Blaak H, van der Ende ME, Boers PH, Schuitemaker H, Osterhaus AD. Blaak H, et al. Among authors: van der ende me. Virology. 2006 Sep 15;353(1):144-54. doi: 10.1016/j.virol.2006.05.029. Epub 2006 Jun 30. Virology. 2006. PMID: 16814357 Free article.

4

CCR5-restricted HIV type 2 variants from long-term aviremic individuals are less sensitive to inhibition by beta-chemokines than low pathogenic HIV type 1 variants.

Blaak H, Boers PH, van der Ende ME, Schuitemaker H, Osterhaus AD. Blaak H, et al. Among authors: van der ende me. AIDS Res Hum Retroviruses. 2008 Mar;24(3):473-84. doi: 10.1089/aid.2007.0001. AIDS Res Hum Retroviruses. 2008. PMID: 18327978

5

Determination of the antiretroviral drug tenofovir in plasma from HIV-infected adults by ultrafast isotope dilution MALDI-triple quadrupole tandem mass spectrometry.

Meesters RJ, van Kampen JJ, Scheuer RD, van der Ende ME, Gruters RA, Luider TM. Meesters RJ, et al. Among authors: van der ende me, van kampen jj. J Mass Spectrom. 2011 Mar;46(3):282-9. doi: 10.1002/jms.1897. J Mass Spectrom. 2011. PMID: 21394844

6

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption.

Allard SD, De Keersmaecker B, de Goede AL, Verschuren EJ, Koetsveld J, Reedijk ML, Wylock C, De Bel AV, Vandeloo J, Pistoor F, Heirman C, Beyer WE, Eilers PH, Corthals J, Padmos I, Thielemans K, Osterhaus AD, Lacor P, van der Ende ME, Aerts JL, van Baalen CA, Gruters RA. Allard SD, et al. Among authors: van der ende me, van baalen ca. Clin Immunol. 2012 Mar;142(3):252-68. doi: 10.1016/j.clim.2011.10.010. Epub 2011 Nov 16. Clin Immunol. 2012. PMID: 22177848 Clinical Trial.

7

Hcv coinfection, an important risk factor for hepatotoxicity in pregnant women starting antiretroviral therapy.

Snijdewind IJ, Smit C, Godfried MH, Nellen JF, de Wolf F, Boer K, van der Ende ME. Snijdewind IJ, et al. Among authors: van der ende me. J Infect. 2012 Apr;64(4):409-16. doi: 10.1016/j.jinf.2011.12.012. Epub 2011 Dec 23. J Infect. 2012. PMID: 22227465 Free article.

8

Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection.

Khalid M, Yu H, Sauter D, Usmani SM, Schmokel J, Feldman J, Gruters RA, van der Ende ME, Geyer M, Rowland-Jones S, Osterhaus AD, Kirchhoff F. Khalid M, et al. Among authors: van der ende me. J Virol. 2012 May;86(9):4906-20. doi: 10.1128/JVI.06856-11. Epub 2012 Feb 15. J Virol. 2012. PMID: 22345473 Free PMC article.

9

Therapy failure resulting from superinfection by a drug-resistant HIV variant.

Pingen M, Nouwen JL, Dinant S, Albert J, Mild M, Brodin J, Simen BB, Walsh S, Kayser M, van der Ende ME, Schutten M, Boucher CA. Pingen M, et al. Among authors: van der ende me. Antivir Ther. 2012;17(8):1621-5. doi: 10.3851/IMP2267. Epub 2012 Jul 31. Antivir Ther. 2012. PMID: 22846173

10

The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals.

Yu H, Usmani SM, Borch A, Krämer J, Stürzel CM, Khalid M, Li X, Krnavek D, van der Ende ME, Osterhaus AD, Gruters RA, Kirchhoff F. Yu H, et al. Among authors: van der ende me. Retrovirology. 2013 Mar 5;10:27. doi: 10.1186/1742-4690-10-27. Retrovirology. 2013. PMID: 23497283 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page